Cord Blood Registry® (CBR®) is launching an FDA-regulated clinical trial to investigate autologous stem cell therapy in children diagnosed as having had a prenatal or perinatal pediatric stroke.Continue reading
Author Archive: AZBio
A Vote for Our Future: 21st Century Cures Passes in the House
In a 344 to 77 vote, the U.S. House of Representatives passed H.R.6: The 21st Century Cures Act on the morning of July 10, 2015. Continue reading
NSF Award Propels Northern Arizona University Team Toward All-Terrain Prosthetic
Researchers slogging through a tangle of sensors, motors and algorithms face a challenging path, but it’s nothing like the terrain that must be crossed by someone walking with a prosthetic ankle.Continue reading
Doctors to Get Better Access to Digital Data
UA researchers are developing software that lets doctors more quickly and effectively analyze digitized biomedical images like this one of breast tissue. Continue reading
UA Startup to Develop Cancer Treatment
A drug by Synactix Pharmaceuticals starves and obstructs tumor growth by preventing blood vessel formation and oncogene signaling.Continue reading
Studies evaluate new technology for life-saving lung cancer screening
ignificant Lung Cancer Screening Study Published in the American Cancer Society Journal, Cancer Cytopathology
– Two newly published articles demonstrate potential for lung cancer screening using sputum
Theranos Achieves Major Milestone with FDA Clearance
Theranos receives FDA clearance and review and validation of revolutionary finger stick technology, test, and associated test system: Major milestone for Theranos and national preventive health care landscape – Press releases
Accelerate Diagnostics Achieves CE-IVD Milestone and Expands Preclinical Study
Accelerate Diagnostics Achieves CE-IVD Milestone for ID/AST System and ID/AST Blood Culture AssayContinue reading
AMAG Pharmaceuticals to Acquire CBR for $700M
NuvOx Pharma Files Patent Application with University of Pittsburgh in Sickle Cell Disease
NuvOx Pharma has completed a licensing agreement with the University of Pittsburgh for a patent application entitled, “Treatment of Acute Complications of Sickle Cell Disease.”Continue reading